2004
DOI: 10.1038/nbt1038
|View full text |Cite
|
Sign up to set email alerts
|

Lack of interferon response in animals to naked siRNAs

Abstract: Supplementary Figure 1 RNase digestion of poly(I:C) and siRNA. RNase degradation of poly(I:C). 1 µg poly(I:C) was incubated with RNase (at indicated concentrations from 0-50 µg/mL) at 37 o C for 30 min, then electrophoresed on a 1% (wt/vol) agarose gel.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
108
0
1

Year Published

2006
2006
2021
2021

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 167 publications
(118 citation statements)
references
References 30 publications
9
108
0
1
Order By: Relevance
“…On the contrary, other findings demonstrate that is even possible to administer naked, synthetic siRNA to mice without inducing any interferon response (Heidel et al, 2004). In our experimental model, we analysed the phosphorylation status (on Tyr701) of STAT-1 protein as a marker of the interferon system activation (Brierley and Fish, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…On the contrary, other findings demonstrate that is even possible to administer naked, synthetic siRNA to mice without inducing any interferon response (Heidel et al, 2004). In our experimental model, we analysed the phosphorylation status (on Tyr701) of STAT-1 protein as a marker of the interferon system activation (Brierley and Fish, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…4C), consistent with recent reports using naked siRNAs. 37 Next, mice were injected into the tail 2 consecutive days with either ASMase-siRNA or scrambled siRNA and then subjected to I/R the day after the last dose. ASMase-siRNA decreased hepatic ASMase mRNA levels (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…siRNA has been administered into cerebroventricles, vasculature, intrathecal space, and parenchyma (16)(17)(18)(19)(20). siRNAs were found effective and safe when introduced into mice and non-human primates (19,21,22). Several limitations impede progress in using siRNAs as a treatment for HD: entry and effectiveness in adult neurons without the use of potentially toxic transfection reagents; a clear demonstration that gene silencing reduces protein expression; and an improvement in behavioral deficits and neuropathology, especially neuron survival.…”
Section: H Untington's Disease (Hd) Is An Autosomal Dominant Diseasementioning
confidence: 99%